Search Results - "Gaetani, Silvana"

Refine Results
  1. 1

    Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target by Cassano, Tommaso, Calcagnini, Silvio, Pace, Lorenzo, De Marco, Federico, Romano, Adele, Gaetani, Silvana

    Published in Frontiers in neuroscience (02-02-2017)
    “…As a consequence of an increasingly aging population, the number of people affected by neurodegenerative disorders, such as Alzheimer's disease, Parkinson's…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery by Trapani, Adriana, De Giglio, Elvira, Cafagna, Damiana, Denora, Nunzio, Agrimi, Gennaro, Cassano, Tommaso, Gaetani, Silvana, Cuomo, Vincenzo, Trapani, Giuseppe

    Published in International journal of pharmaceutics (31-10-2011)
    “…The aim of this study was to characterize nanoparticles (NPs) composed of chitosan (CS) and evaluate their potential for brain delivery of the neurotransmitter…”
    Get full text
    Journal Article
  4. 4

    Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease by Barone, Eugenio, Tramutola, Antonella, Triani, Francesca, Calcagnini, Silvio, Di Domenico, Fabio, Ripoli, Cristian, Gaetani, Silvana, Grassi, Claudio, Butterfield, D Allan, Cassano, Tommaso, Perluigi, Marzia

    Published in Molecular neurobiology (01-04-2019)
    “…Impairment of biliverdin reductase-A (BVR-A) is an early event leading to brain insulin resistance in AD. Intranasal insulin (INI) administration is under…”
    Get full text
    Journal Article
  5. 5

    Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review by Di Giacomo, Silvia, Percaccio, Ester, Gullì, Marco, Romano, Adele, Vitalone, Annabella, Mazzanti, Gabriela, Gaetani, Silvana, Di Sotto, Antonella

    Published in Nutrients (01-09-2022)
    “…Alzheimer's disease (AD) is a progressive degenerative disorder of the central nervous system, characterized by neuroinflammation, neurotransmitter deficits,…”
    Get full text
    Journal Article
  6. 6

    The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease by Bedse, Gaurav, Romano, Adele, Lavecchia, Angelo M, Cassano, Tommaso, Gaetani, Silvana

    Published in Journal of Alzheimer's disease (01-01-2015)
    “…Alzheimer's disease (AD) is the most common form of progressive neurodegenerative disease characterized by cognitive impairment and mental disorders. The…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9

    Glutamate and Mitochondria: Two Prominent Players in the Oxidative Stress-Induced Neurodegeneration by Cassano, Tommaso, Pace, Lorenzo, Bedse, Gaurav, Lavecchia, Angelo Michele, De Marco, Federico, Gaetani, Silvana, Serviddio, Gaetano

    Published in Current Alzheimer research (01-02-2016)
    “…The aetiology of major neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) is still unknown, but increasing evidences…”
    Get more information
    Journal Article
  10. 10
  11. 11

    From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders by Romano, Adele, Tempesta, Bianca, Micioni Di Bonaventura, Maria Vittoria, Gaetani, Silvana

    Published in Frontiers in neuroscience (12-01-2016)
    “…Oxytocin (oxy) is a pituitary neuropeptide hormone synthesized from the paraventricular and supraoptic nuclei within the hypothalamus. Like other…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task by Cassano, Tommaso, Calcagnini, Silvio, Carbone, Antonio, Bukke, Vidyasagar Naik, Orkisz, Stanislaw, Villani, Rosanna, Romano, Adele, Avolio, Carlo, Gaetani, Silvana

    Published in Frontiers in pharmacology (27-09-2019)
    “…Besides the memory impairment, Alzheimer’s disease (AD) is often complicated by neuropsychiatric symptoms also known as behavioral and psychological symptoms…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Food Intake Regulates Oleoylethanolamide Formation and Degradation in the Proximal Small Intestine by Fu, Jin, Astarita, Giuseppe, Gaetani, Silvana, Kim, Janet, Cravatt, Benjamin F., Mackie, Ken, Piomelli, Daniele

    Published in The Journal of biological chemistry (12-01-2007)
    “…Oleoylethanolamide (OEA) is a lipid mediator that inhibits food intake by activating the nuclear receptor peroxisome proliferator-activated receptor-α. In the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The Role of Brain Cholesterol and its Oxidized Products in Alzheimer's Disease by Giudetti, Anna Maria, Romano, Adele, Lavecchia, Angelo Michele, Gaetani, Silvana

    Published in Current Alzheimer research (01-02-2016)
    “…The human brain is the most cholesterol-rich organ harboring 25% of the total cholesterol pool of the whole body. Cholesterol present in the central nervous…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues by Gallelli, Cristina Anna, Calcagnini, Silvio, Romano, Adele, Koczwara, Justyna Barbara, de Ceglia, Marialuisa, Dante, Donatella, Villani, Rosanna, Giudetti, Anna Maria, Cassano, Tommaso, Gaetani, Silvana

    Published in Antioxidants (18-07-2018)
    “…Growing evidence supports the pivotal role played by oxidative stress in tissue injury development, thus resulting in several pathologies including…”
    Get full text
    Journal Article